[Antitumor polychemotherapy].
D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011372:Progestins / Q000627:therapeutic use*
D000963:Antimetabolites; D000970:Antineoplastic Agents; D006834:Hydrazines; D006908:Hydroxyprogesterones; D009588:Nitrogen Mustard Compounds; D011372:Progestins; D002699:Chlorambucil; D003520:Cyclophosphamide; D008525:Medroxyprogesterone; D005472:Fluorouracil; D008727:Methotrexate
Polychimiothérapie antitumorale.